HIP1-ALK–Rearranged Lung Cancer in a Young Adult With BRAF V600E Mutation Detected After ALK Tyrosine Kinase Inhibitor Therapy: A Case Report by Aiko Ogimoto, MD, Naoko Katsurada, MD, PhD, Atsuhiko Yatani, MD, Chihiro Mimura, MD, Masatsugu Yamamoto, MD, PhD, Motoko Tachihara, MD, PhD

Get full text